Endogenous cytokine production protects T cells from spontaneous apoptosis during highly active antiretroviral therapy

HIV Medicine

Volumn 3, Issue 2, 2002, Pages 105-117

  Ensoli, F ^a,b   Fiorelli, V ^a,c   De Cristofaro, M ^a   Collacchi, B ^a   Santini Muratori, D ^a   Alario, C ^a   Sacco, G ^a   Iebba, F ^a   Aiuti, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Istituto Superiore di Sanità ^*  (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AIDS HIV; Apoptosis; Cytokines; Th1 Th2

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 4; LECTIN; LIPOCORTIN 5; NEUTRALIZING ANTIBODY; PROPIDIUM IODIDE; PROTEINASE INHIBITOR;

ADULT; APOPTOSIS; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; MONONUCLEAR CELL; NICK END LABELING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS REPLICATION;

ANTIBODIES, MONOCLONAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HUMANS; IN SITU NICK-END LABELING; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; NEUTRALIZATION TESTS; T-LYMPHOCYTES; VIRAL LOAD;

EID: 0036262280     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1293.2002.00107.x     Document Type: Article

References (44)

1. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
2. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+T cell population with memory rather than naive cells
3. Long-term evaluation of T cell subsets and T cell function after highly active antiretroviral therapy in advanced stage of HIV-1 disease
4. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
5. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
6. Apoptosis and the CD95 system in HIV disease: Impact of highly active anti-retroviral therapy (HAART)
7. Decreased T cell apoptosis and T cell recovery during highly active antiretroviral therapy (HAART)
8. Direct and indirect mechanisms mediating apoptosis during HIV infection: Contribution to in vivo CD4 T cell depletion
9. Programmed death of T cells in HIV-1 infection
10. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis
11. Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule
12. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4
13. HIV type 1 Tat protein enhances activation-but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals
14. Dual role of HIV Tat in regulation of apoptosis in T cells
15. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
16. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8
17. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
18. Chronically HIV-1-infected monocytic cells induce apoptosis in cocultured T cells
19. Rapid and selective depletion of CD4+ T lymphocytes and preferential loss of memory cells on interaction of mononuclear cells with HIV-1 glycoprotein-expressing cells
20. Altered cytokine production and accessory cell function after HIV-1 infection
21. Infection and apoptotic cell death of CD4+ T cells during an immune response to HIV-1-pulsed dendritic cells
22. Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin
23. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokines and protease antagonists
24. Apoptosis in HIV infection: Protective role of IL-2
25. TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals
26. Role of TH1/TH2 cytokines in HIV infection
27. Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication
28. Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines
29. Cytokines and the immune response
30. Detection and characterization of apoptotic peripheral blood lymphocytes in HIV-1 infection and cancer chemotherapy by a novel flow immunocytometric method
31. Detection of low HIV-1 RNA levels in plasma
32. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: Enhanced sensitivity
33. Inflammatory cytokines and HIV-1-associated neurodegeneration: Oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons
34. Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy
35. Recovery of haematopoietic abnormalities in HIV-1 infected patients treated with HAART
36. Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA)
37. Apoptosis of CD4+ and CD8+ T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection
38. Programmed cell death in peripheral lymphocytes from HIV-infected persons. Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocytre activation and with disease progression
39. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden
40. From cell activation to cell depletion. The programmed cell death hypothesis of AIDS pathogenesis
41. Programmed cell death and AIDS: Significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections
42. An inhibitor of HIV-1 protease modulates proteosome activity, antigen presentation, and T cell responses
43. HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells
44. Circulating CD8 T lymphocyte in human immunodeficiency virus infected individuals have impaired functions and downmodulate CD3 zeta, the signaling chain of the T cell receptor complex